Trial Profile
Pharmacokinetics, pharmacodynamics and tolerability of prasugrel in healthy Chines subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jan 2015
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Acute coronary syndromes; Sickle cell anaemia; Stroke
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Eli Lilly and Company
- 08 Jan 2015 New trial record